Seattle Genetics (SGEN) Medical Chief Reynolds to Resign
Tweet
Share
E-mailGet Alerts SGEN Hot Sheet
Join SI Premium – FREE
On October 30, 2012, Thomas C. Reynolds, M.D., Ph.D., Chief Medical Officer of Seattle Genetics, Inc. (Nasdaq: SGEN), informed the Company of his resignation in connection with his retirement for a family health matter. Dr. Reynolds will continue to serve as the Company’s Chief Medical Officer until December 31, 2012. Dr. Reynolds has been a key contributor at Seattle Genetics, notably through his leadership of the Company’s clinical and regulatory teams during the development and approval of ADCETRIS®. The Company has started a search for a replacement to Dr. Reynolds and anticipates a seamless transition of responsibilities over the next several months.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Home Depot expands executive roles, grants $500K in restricted stock
- AEye grants 125,000 RSUs to new chief revenue officer
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
